4YVX image
Deposition Date 2015-03-20
Release Date 2015-11-25
Last Version Date 2023-11-08
Entry Detail
PDB ID:
4YVX
Keywords:
OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR
Title:
Crystal structure of AKR1C3 complexed with glimepiride
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Escherichia coli
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.30 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1
4YVX validation report
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Aldo-keto reductase family 1 member C3
Gene (Uniprot):AKR1C3
Chain IDs:A, B
Chain Length:323
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:P42330 Pfam ID:PF00248 EC:1.1.1.188
Ligand Molecules
GMR
NAP
Primary Citation
In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis
Chem.Biol.Interact. 240 310 315 (2015)
PMID: 26362498 DOI: 10.1016/j.cbi.2015.09.006

Abstact

Recent epidemiological studies show conflicting data for the first-line anti-diabetic sulphonylureas drugs in treating cancer progression in type II diabetes patients. How sulphonylureas promote or diminish tumor growth is not fully understood. Here, we report that seven sulphonylureas exhibit different in vitro inhibition towards AKR1Cs (AKR1C1, AKR1C2, AKR1C3), which are critical steroid hormone metabolism enzymes that are related to prostate cancer, breast cancer and endometrial diseases. Interactions of the sulphonylureas and AKR1Cs were analyzed by X-ray crystallography.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
4YVP
4YVV